28 results on '"Rigouts, Leen"'
Search Results
2. Spatial distribution of tuberculosis in Cochabamba, socioeconomic determinants and catastrophic costs for households
- Author
-
UCL - SSS/IREC/EPID - Pôle d'épidémiologie et biostatistique, UCL - Faculté de santé publique, Robert, Annie, Speybroeck, Niko, Yombi, Jean Cyr, Wanlin, Maryse, Rigouts, Leen, Martin, Anandi, Gosset, Christiane, Wimet-Dramaix, Michèle, Rojas Mattos, Marcelo, UCL - SSS/IREC/EPID - Pôle d'épidémiologie et biostatistique, UCL - Faculté de santé publique, Robert, Annie, Speybroeck, Niko, Yombi, Jean Cyr, Wanlin, Maryse, Rigouts, Leen, Martin, Anandi, Gosset, Christiane, Wimet-Dramaix, Michèle, and Rojas Mattos, Marcelo
- Abstract
Socioeconomic variables contribute to the burden and the spread of the tuberculosis, especially in developing countries. Likewise, patients with tuberculosis usually incur large costs directly related to their disease. Additional indirect costs also increase the economic burden of households creating barriers of access and adherence that can affect the healing of patients. The objective of our thesis was to determine the distribution of tuberculosis, its relationship to socio-economic determinants and assess the socio-economic consequences for patients and their households affected by the disease in the department of Cochabamba, Bolivia. Therefore, on the one hand we conducted an ecological study to evaluate the spatial distribution of tuberculosis and its relationship with socioeconomic determinants and the other hand we conducted a cross-sectional study with retrospective data collection to determine the socioeconomic impact of TB on patients and their households. We found that each region of the Department showed different values and characteristics regarding not only the incidence of tuberculosis but also regarding geography and socioeconomic variables, reflecting different realities in the five regions. The distribution pattern of the incidence of tuberculosis highlighted a high incidence in the Tropicals Regions, a moderate incidence in the Metropolitans Regions and a low incidence in the Valleys, Southern Cone and Andean Regions. The relationship between the incidence of tuberculosis and socioeconomic variables was also different between Regions. However, the variable "not homeowner" correlated positively with the incidence of tuberculosis in each Region. This variable has a very important link with the economic situation of households, because people who do not have their own home go to rental contracts that are usually associated with precarious conditions and the overcrowding of people, increasing risk of tuberculosis contamination. Likewise, we found that, (SP - Sciences de la santé publique) -- UCL, 2022
- Published
- 2022
3. Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
- Author
-
Ministerio de Ciencia e Innovación (España), European Research Council, Comas, Iñaki [0000-0001-5504-9408], Antimycobacterial Susceptibility Testing Group, Georghiou, Sophia B., Rodwell, Timothy C., Korobitsyn, Alexei, Abbadi, Said H., Ajbani, Kanchan, Alffenaar, Jan-Willem, Alland, David, Alvarez, Nataly, Andres, Sönke, Ardizzoni, Elisa, Aubry, Alexandra, Baldan, Rossella, Ballif, Marie, Barilar, Ivan, Böttger, Erik C., Chakravorty, Soumitesh, Claxton, Pauline M., Cirillo, Daniela M., Comas, Iñaki, Coulter, Chris, Denkinger, Claudia M., Derendinger, Brigitta, Desmond, Edward P., Steenwinkel, Jurriaan E. M. de, Dheda, Keertan, Diacon, Andreas H., Dolinger, David L., Dooley, Kelly E., Egger, Matthias, Ehsani, Soudeh, Farhat, Maha R., Fattorini, Lanfranco, Finci, Iris, Fournier Le Ray, Laure, Furió, Victoria, Groenheit, Ramona, Gumbo, Tawanda, Heysell, Scott K., Hillemann, Doris, Hoffmann, Harald, Hsueh, Po-Ren, Hu, Yi, Huang, Hairong, Hussain, Alamdar, Ismail, Farzana, Izumi, Kiyohiko, Jagielski, Tomasz, Johnson, John L., Kambli, Priti, Kaniga, Koné, Karunaratne, G. H. R. Eranga, Sharma, Meenu Kaushal, Keller, Peter M., Kelly, Ellis C., Kholina, Margarita, Kohli, Mikashmi, Kranzer, Katharina, Laurenson, Ian F., Limberis, Jason, Lin, S-Y. Grace, Liu, Yongge, López-Gavín, Alexandre, Lyander, Anna, Machado, Diana, Martínez, Elena, Masood, Faisal, Mitarai, Satoshi, Mvelase, Nomonde R., Niemann, Stefan, Nikolayevskyy, Vladyslav, Maurer, Florian P., Merker, Matthias, Miotto, Paolo, Omar, Shaheed V., Otto-Knapp, Ralf, Palaci, Moisés, Palacios Gutiérrez, Juan José, Peacock, Sharon J., Peloquin, Charles A., Perera, Jennifer, Pierre-Audigier, Catherine, Pholwat, Suporn, Posey, James E., Prammananan, Therdsak, Rigouts, Leen, Robledo, Jaime, Rockwood, Neesha, Rodrigues, Camilla, Salfinger, Max, Schechter, Marcos C., Seifert, Marva, Sengstake, Sarah, Shinnick, Thomas, Shubladze, Natalia, Sintchenko, Vitali, Sirgel, Frederick, Somasundaram, Sulochana, Sterling, Timothy R., Spitaleri, Andrea, Streicher, Elizabeth, Supply, Philip, Svensson, Erik, Tagliani, Elisa, Tahseen, Sabira, Takaki, Akiko, Theron, Grant, Torrea, Gabriela, Van Deun, Armand, van Ingen, Jakko, Van Rie, Annelies, van Soolingen, Dick, Vargas Jr, Roger, Venter, Amour, Veziris, Nicolas, Villellas, Cristina, Viveiros, Miguel, Warren, Robin, Wen, Shu'an, Werngren, Jim, Wilkinson, Robert J., Yang, Caie, Yılmaz, F. Ferda, Zhang, Tingting, Zimenkov, Danila, Ismail, Nazir, Köser, Claudio U., Schön, Thomas, Ministerio de Ciencia e Innovación (España), European Research Council, Comas, Iñaki [0000-0001-5504-9408], Antimycobacterial Susceptibility Testing Group, Georghiou, Sophia B., Rodwell, Timothy C., Korobitsyn, Alexei, Abbadi, Said H., Ajbani, Kanchan, Alffenaar, Jan-Willem, Alland, David, Alvarez, Nataly, Andres, Sönke, Ardizzoni, Elisa, Aubry, Alexandra, Baldan, Rossella, Ballif, Marie, Barilar, Ivan, Böttger, Erik C., Chakravorty, Soumitesh, Claxton, Pauline M., Cirillo, Daniela M., Comas, Iñaki, Coulter, Chris, Denkinger, Claudia M., Derendinger, Brigitta, Desmond, Edward P., Steenwinkel, Jurriaan E. M. de, Dheda, Keertan, Diacon, Andreas H., Dolinger, David L., Dooley, Kelly E., Egger, Matthias, Ehsani, Soudeh, Farhat, Maha R., Fattorini, Lanfranco, Finci, Iris, Fournier Le Ray, Laure, Furió, Victoria, Groenheit, Ramona, Gumbo, Tawanda, Heysell, Scott K., Hillemann, Doris, Hoffmann, Harald, Hsueh, Po-Ren, Hu, Yi, Huang, Hairong, Hussain, Alamdar, Ismail, Farzana, Izumi, Kiyohiko, Jagielski, Tomasz, Johnson, John L., Kambli, Priti, Kaniga, Koné, Karunaratne, G. H. R. Eranga, Sharma, Meenu Kaushal, Keller, Peter M., Kelly, Ellis C., Kholina, Margarita, Kohli, Mikashmi, Kranzer, Katharina, Laurenson, Ian F., Limberis, Jason, Lin, S-Y. Grace, Liu, Yongge, López-Gavín, Alexandre, Lyander, Anna, Machado, Diana, Martínez, Elena, Masood, Faisal, Mitarai, Satoshi, Mvelase, Nomonde R., Niemann, Stefan, Nikolayevskyy, Vladyslav, Maurer, Florian P., Merker, Matthias, Miotto, Paolo, Omar, Shaheed V., Otto-Knapp, Ralf, Palaci, Moisés, Palacios Gutiérrez, Juan José, Peacock, Sharon J., Peloquin, Charles A., Perera, Jennifer, Pierre-Audigier, Catherine, Pholwat, Suporn, Posey, James E., Prammananan, Therdsak, Rigouts, Leen, Robledo, Jaime, Rockwood, Neesha, Rodrigues, Camilla, Salfinger, Max, Schechter, Marcos C., Seifert, Marva, Sengstake, Sarah, Shinnick, Thomas, Shubladze, Natalia, Sintchenko, Vitali, Sirgel, Frederick, Somasundaram, Sulochana, Sterling, Timothy R., Spitaleri, Andrea, Streicher, Elizabeth, Supply, Philip, Svensson, Erik, Tagliani, Elisa, Tahseen, Sabira, Takaki, Akiko, Theron, Grant, Torrea, Gabriela, Van Deun, Armand, van Ingen, Jakko, Van Rie, Annelies, van Soolingen, Dick, Vargas Jr, Roger, Venter, Amour, Veziris, Nicolas, Villellas, Cristina, Viveiros, Miguel, Warren, Robin, Wen, Shu'an, Werngren, Jim, Wilkinson, Robert J., Yang, Caie, Yılmaz, F. Ferda, Zhang, Tingting, Zimenkov, Danila, Ismail, Nazir, Köser, Claudio U., and Schön, Thomas
- Abstract
Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance.
- Published
- 2022
4. Targeted next-generation sequencing of sputum for diagnosis of drug-resistant TB: results of a national survey in Democratic Republic of the Congo.
- Author
-
UCL - SSS/IREC/MBLG - Pôle de Microbiologie médicale, Kayomo, Michel Kaswa, Mbula, Vital Nkake, Aloni, Muriel, André, Emmanuel, Rigouts, Leen, Boutachkourt, Fairouz, de Jong, Bouke C, Nkiere, Nicolas M, Dean, Anna S, UCL - SSS/IREC/MBLG - Pôle de Microbiologie médicale, Kayomo, Michel Kaswa, Mbula, Vital Nkake, Aloni, Muriel, André, Emmanuel, Rigouts, Leen, Boutachkourt, Fairouz, de Jong, Bouke C, Nkiere, Nicolas M, and Dean, Anna S
- Abstract
The surveillance of drug resistance among tuberculosis (TB) patients is central to preventing the spread of antimicrobial resistance. The Democratic Republic of the Congo (DR Congo) is classified by the World Health Organization (WHO) as a country with a high burden of TB and multidrug-resistant TB (MDR-TB), but there are no nationally representative data on drug resistance. In 2016-2017, a national survey of TB patients was conducted in 108 microscopy centres across all 11 provinces of the country using innovative molecular approaches. Sputum samples were collected from 1,545 new and 163 previously treated patients. These were tested by the Xpert MTB/RIF assay, followed by targeted next-generation sequencing performed directly on sputum. The prevalence of rifampicin resistance was low, at 1.8% (95% CI: 1.0-3.2) among new and 17.3% (95% CI: 11.9-24.4) among previously treated patients. Resistance to pyrazinamide, fluoroquinolones and second-line injectables was also low. The prevalence of resistance to isoniazid among rifampicin-susceptible patients was higher, at 6.6% (95% CI: 4.4-9.8) among new and 8.7% (95% : 3.2-21.2) among previously treated patients. Diagnosing and treating isoniazid-resistant patients remains a challenge, given that many will be missed by the current national diagnostic algorithm that is driven by detecting rifampicin resistance by Xpert MTB/RIF. This is the first nationwide survey incorporating targeted sequencing directly on sputum. It serves as a proof-of-concept for other settings that do yet have rapid specimen transport networks or capacity to conduct culture.
- Published
- 2020
5. Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
- Author
-
Ezewudo, Matthew, Ezewudo, Matthew, Borens, Amanda, Chiner-Oms, Álvaro, Miotto, Paolo, Chindelevitch, Leonid, Starks, Angela M, Hanna, Debra, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Kohl, Thomas Andreas, Warren, Robin M, Crook, Derrick, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, McNerney, Ruth, Cirillo, Daniela M, Schito, Marco, Rodwell, Timothy C, Posey, James, Ezewudo, Matthew, Ezewudo, Matthew, Borens, Amanda, Chiner-Oms, Álvaro, Miotto, Paolo, Chindelevitch, Leonid, Starks, Angela M, Hanna, Debra, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Kohl, Thomas Andreas, Warren, Robin M, Crook, Derrick, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, McNerney, Ruth, Cirillo, Daniela M, Schito, Marco, Rodwell, Timothy C, and Posey, James
- Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2020
6. Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
- Author
-
UCL - (SLuc) Service de microbiologie, Torrea, Gabriela, Ng, Kamela C. S., Van Deun, Armand, André, Emmanuel, Kaisergruber, Justine, Ssengooba, Willy, Desmaretz, Christel, Gabriels, Siemon, Driesen, Michèle, Diels, Maren, Asnong, Sylvie, Fissette, Kristina, Gumusboga, Mourad, Rigouts, Leen, Affolabi, Dissou, Joloba, Moses, De Jong, Bouke C., UCL - (SLuc) Service de microbiologie, Torrea, Gabriela, Ng, Kamela C. S., Van Deun, Armand, André, Emmanuel, Kaisergruber, Justine, Ssengooba, Willy, Desmaretz, Christel, Gabriels, Siemon, Driesen, Michèle, Diels, Maren, Asnong, Sylvie, Fissette, Kristina, Gumusboga, Mourad, Rigouts, Leen, Affolabi, Dissou, Joloba, Moses, and De Jong, Bouke C.
- Abstract
We compared the ability of commercial and non-commercial, phenotypic and genotypic rapid drug susceptibility tests (DSTs) to detect rifampicin resistance (RR)-conferring ‘disputed’ mutations frequently missed by Mycobacterium Growth Indicator Tube (MGIT), namely L430P, D435Y, L452P, and I491F. Strains with mutation S450L served as positive control while wild-types were used as negative control. Of the 38 mutant strains, 5.7% were classifed as RR by MGIT, 16.2% by Trek Sensititre MYCOTB MIC plate, 19.4% by resazurin microtiter plate assay (REMA), 50.0% by nitrate reductase assay (NRA), and 62.2% by microscopic observation direct susceptibility testing (MODS). Reducing MGIT rifampicin concentration to 0.5µg/ml, and/or increasing incubation time, enhanced detection of disputed mutations from 5.7% to at least 65.7%, particularly for mutation I491F (from 0.0 to 75.0%). Compared with MGIT at standard pre-set time with 0.25µg/ml ECOFF as breakpoint, we found a statistically signifcant increase in the ability of MGIT to resolve disputed mutants and WT strains at extended incubation period of 15 and 21 days, with 0.5µg/ml and 1µg/ml ECOFF respectively. MODS detected 75.0% of the I491F strains and NRA 62.5%, while it was predictably missed by all molecular assays. Xpert MTB/RIF, Xpert Ultra, and GenoscholarTB-NTM+MDRTB detected all mutations within the 81bp RR determining region. Only GenoType MTBDRplus version 2 missed mutation L430P in 2 of 11 strains. Phenotypic and genotypic DSTs varied greatly in detecting occult rifampicin resistance. None of these methods detected all disputed mutations without misclassifying wild-type strains.
- Published
- 2019
7. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
- Author
-
European Research Council, National Institutes of Health (US), University of British Columbia, German Center for Infection Research, German Research Foundation, Research Foundation - Flanders, Comas, Iñaki [0000-0001-5504-9408], Goig, Galo A. [0000-0002-4136-6610], Meehan, Conor J., Goig, Galo A., Kohl, Thomas A., Verboven, Lennert, Dippenaar, Anzaan, Ezewudo, Matthew, Farhat, Maha R., Guthrie, Jennifer L., Laukens, Kris, Miotto, Paolo, Ofori-Anyinam, Boatema, Dreyer, Viola, Supply, Philip, Suresh, Anita, Utpatel, Christian, van Soolingen, Dick, Zhou, Yang, Ashton, Philip M., Brites, Daniela, Cabibbe, Andrea M., de Jong, Bouke C., de Vos, Margaretha, Menardo, Fabrizio, Gagneux, Sebastien, Gao, Qian, Heupink, Tim H., Liu, Qingyun, Loiseau, Chloé, Rigouts, Leen, Rodwell, Timothy C., Tagliani, Elisa, Walker, Timothy M., Warren, Robin M., Zhao, Yanlin, Zignol, Matteo, Schito, Marco, Gardy, Jennifer, Cirillo, Daniela M., Niemann, Stefan, Comas, Iñaki, Van Rie, Annelies, European Research Council, National Institutes of Health (US), University of British Columbia, German Center for Infection Research, German Research Foundation, Research Foundation - Flanders, Comas, Iñaki [0000-0001-5504-9408], Goig, Galo A. [0000-0002-4136-6610], Meehan, Conor J., Goig, Galo A., Kohl, Thomas A., Verboven, Lennert, Dippenaar, Anzaan, Ezewudo, Matthew, Farhat, Maha R., Guthrie, Jennifer L., Laukens, Kris, Miotto, Paolo, Ofori-Anyinam, Boatema, Dreyer, Viola, Supply, Philip, Suresh, Anita, Utpatel, Christian, van Soolingen, Dick, Zhou, Yang, Ashton, Philip M., Brites, Daniela, Cabibbe, Andrea M., de Jong, Bouke C., de Vos, Margaretha, Menardo, Fabrizio, Gagneux, Sebastien, Gao, Qian, Heupink, Tim H., Liu, Qingyun, Loiseau, Chloé, Rigouts, Leen, Rodwell, Timothy C., Tagliani, Elisa, Walker, Timothy M., Warren, Robin M., Zhao, Yanlin, Zignol, Matteo, Schito, Marco, Gardy, Jennifer, Cirillo, Daniela M., Niemann, Stefan, Comas, Iñaki, and Van Rie, Annelies
- Abstract
Whole genome sequencing (WGS) of Mycobacterium tuberculosis has rapidly progressed from a research tool to a clinical application for the diagnosis and management of tuberculosis and in public health surveillance. This development has been facilitated by drastic drops in cost, advances in technology and concerted efforts to translate sequencing data into actionable information. There is, however, a risk that, in the absence of a consensus and international standards, the widespread use of WGS technology may result in data and processes that lack harmonization, comparability and validation. In this Review, we outline the current landscape of WGS pipelines and applications, and set out best practices for M. tuberculosis WGS, including standards for bioinformatics pipelines, curated repositories of resistance-causing variants, phylogenetic analyses, quality control and standardized reporting.
- Published
- 2019
8. Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
- Author
-
Ezewudo, Matthew, Ezewudo, Matthew, Borens, Amanda, Chiner-Oms, Álvaro, Miotto, Paolo, Chindelevitch, Leonid, Starks, Angela M, Hanna, Debra, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Kohl, Thomas Andreas, Warren, Robin M, Crook, Derrick, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, McNerney, Ruth, Cirillo, Daniela M, Schito, Marco, Rodwell, Timothy C, Posey, James, Ezewudo, Matthew, Ezewudo, Matthew, Borens, Amanda, Chiner-Oms, Álvaro, Miotto, Paolo, Chindelevitch, Leonid, Starks, Angela M, Hanna, Debra, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Kohl, Thomas Andreas, Warren, Robin M, Crook, Derrick, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, McNerney, Ruth, Cirillo, Daniela M, Schito, Marco, Rodwell, Timothy C, and Posey, James
- Abstract
Drug-resistant tuberculosis poses a persistent public health threat. The ReSeqTB platform is a collaborative, curated knowledgebase, designed to standardize and aggregate global Mycobacterium tuberculosis complex (MTBC) variant data from whole genome sequencing (WGS) with phenotypic drug susceptibility testing (DST) and clinical data. We developed a unified analysis variant pipeline (UVP) ( https://github.com/CPTR-ReSeqTB/UVP ) to identify variants and assign lineage from MTBC sequence data. Stringent thresholds and quality control measures were incorporated in this open source tool. The pipeline was validated using a well-characterized dataset of 90 diverse MTBC isolates with conventional DST and DNA Sanger sequencing data. The UVP exhibited 98.9% agreement with the variants identified using Sanger sequencing and was 100% concordant with conventional methods of assigning lineage. We analyzed 4636 publicly available MTBC isolates in the ReSeqTB platform representing all seven major MTBC lineages. The variants detected have an above 94% accuracy of predicting drug based on the accompanying DST results in the platform. The aggregation of variants over time in the platform will establish confidence-graded mutations statistically associated with phenotypic drug resistance. These tools serve as critical reference standards for future molecular diagnostic assay developers, researchers, public health agencies and clinicians working towards the control of drug-resistant tuberculosis.
- Published
- 2018
9. The Distribution and Origins of Ancient Leprosy
- Author
-
Donoghue, Helen D., Michael Taylor, G., Mendum, Tom A., Stewart, Graham R., Rigouts, Leen, Lee, Oona Y-C., Wu, Houdini H.T., Besra, Gurdyal S., Minnikin, David E., Donoghue, Helen D., Michael Taylor, G., Mendum, Tom A., Stewart, Graham R., Rigouts, Leen, Lee, Oona Y-C., Wu, Houdini H.T., Besra, Gurdyal S., and Minnikin, David E.
- Abstract
Human leprosy is primarily caused by Mycobacterium leprae, but also by the related ‘M. lepromatosis’. Ancient leprosy can be recognised in archaeological materials by the paleopathology associated with multi-bacillary or lepromatous forms of the disease. Whole M. leprae genomes have been obtained from human skeletons, and diagnostic aDNA fragments have been recovered. The derived M. leprae phylogenies, based on single nucleotide polymorphisms, mirror past human migrations, as M. leprae is usually an obligate pathogen. The detection of M. leprae in historical leprosy cases is assisted by the hydrophobic M. leprae cell envelope, which is composed of unusual lipids that can be used as specific biomarkers. Lipid biomarkers are more stable than aDNA and can be detected directly without amplification. Indigenous human leprosy is extinct in Western Europe, but recently, both M. leprae and ‘M. lepromatosis’ were found in British red squirrels. Leprosy may also be found in nine-banded armadillos (Dasypus novemcinctus) where it can cause a zoonotic human infection. Certain leprosy-like diseases, caused by uncultivable species in cats, for example, may be related to M. leprae. The closest extant relatives of leprosy bacilli are probably members of the M. haemophilum taxon, emerging pathogens with genomic and lipid biomarker similarities.
- Published
- 2018
- Full Text
- View/download PDF
10. Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
- Author
-
Bill & Melinda Gates Foundation, Ministerio de Economía y Competitividad (España), European Research Council, Comas, Iñaki [0000-0001-5504-9408], Ezewudo, Matthew, Borens, Amanda, Chiner-Oms, Álvaro, Miotto, Paolo, Chindelevitch, Leonid, Starks, Angela M., Hanna, Debra, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Kohl, Thomas Andreas, Warren, Robin M., Crook, Derrick, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, McNerney, Ruth, Cirillo, Daniela M., Schito, Marco, Rodwell, Timothy C, Posey, James, Bill & Melinda Gates Foundation, Ministerio de Economía y Competitividad (España), European Research Council, Comas, Iñaki [0000-0001-5504-9408], Ezewudo, Matthew, Borens, Amanda, Chiner-Oms, Álvaro, Miotto, Paolo, Chindelevitch, Leonid, Starks, Angela M., Hanna, Debra, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Kohl, Thomas Andreas, Warren, Robin M., Crook, Derrick, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, McNerney, Ruth, Cirillo, Daniela M., Schito, Marco, Rodwell, Timothy C, and Posey, James
- Abstract
Drug-resistant tuberculosis poses a persistent public health threat. The ReSeqTB platform is a collaborative, curated knowledgebase, designed to standardize and aggregate global Mycobacterium tuberculosis complex (MTBC) variant data from whole genome sequencing (WGS) with phenotypic drug susceptibility testing (DST) and clinical data. We developed a unified analysis variant pipeline (UVP) ( https://github.com/CPTR-ReSeqTB/UVP ) to identify variants and assign lineage from MTBC sequence data. Stringent thresholds and quality control measures were incorporated in this open source tool. The pipeline was validated using a well-characterized dataset of 90 diverse MTBC isolates with conventional DST and DNA Sanger sequencing data. The UVP exhibited 98.9% agreement with the variants identified using Sanger sequencing and was 100% concordant with conventional methods of assigning lineage. We analyzed 4636 publicly available MTBC isolates in the ReSeqTB platform representing all seven major MTBC lineages. The variants detected have an above 94% accuracy of predicting drug based on the accompanying DST results in the platform. The aggregation of variants over time in the platform will establish confidence-graded mutations statistically associated with phenotypic drug resistance. These tools serve as critical reference standards for future molecular diagnostic assay developers, researchers, public health agencies and clinicians working towards the control of drug-resistant tuberculosis.
- Published
- 2018
11. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
- Author
-
Miotto, Paolo, Miotto, Paolo, Tessema, Belay, Tagliani, Elisa, Chindelevitch, Leonid, Starks, Angela M, Emerson, Claudia, Hanna, Debra, Kim, Peter S, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Denkinger, Claudia M, Fleming, Joy, Warren, Robin M, Crook, Derrick, Posey, James, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Murray, Megan, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, Ranganathan, Uma Devi K, McNerney, Ruth, Ezewudo, Matthew, Cirillo, Daniela M, Schito, Marco, Köser, Claudio U, Rodwell, Timothy C, Miotto, Paolo, Miotto, Paolo, Tessema, Belay, Tagliani, Elisa, Chindelevitch, Leonid, Starks, Angela M, Emerson, Claudia, Hanna, Debra, Kim, Peter S, Liwski, Richard, Zignol, Matteo, Gilpin, Christopher, Niemann, Stefan, Denkinger, Claudia M, Fleming, Joy, Warren, Robin M, Crook, Derrick, Posey, James, Gagneux, Sebastien, Hoffner, Sven, Rodrigues, Camilla, Comas, Iñaki, Engelthaler, David M, Murray, Megan, Alland, David, Rigouts, Leen, Lange, Christoph, Dheda, Keertan, Hasan, Rumina, Ranganathan, Uma Devi K, McNerney, Ruth, Ezewudo, Matthew, Cirillo, Daniela M, Schito, Marco, Köser, Claudio U, and Rodwell, Timothy C
- Abstract
A clear understanding of the genetic basis of antibiotic resistance in Mycobacterium tuberculosis is required to accelerate the development of rapid drug susceptibility testing methods based on genetic sequence.Raw genotype-phenotype correlation data were extracted as part of a comprehensive systematic review to develop a standardised analytical approach for interpreting resistance associated mutations for rifampicin, isoniazid, ofloxacin/levofloxacin, moxifloxacin, amikacin, kanamycin, capreomycin, streptomycin, ethionamide/prothionamide and pyrazinamide. Mutation frequencies in resistant and susceptible isolates were calculated, together with novel statistical measures to classify mutations as high, moderate, minimal or indeterminate confidence for predicting resistance.We identified 286 confidence-graded mutations associated with resistance. Compared to phenotypic methods, sensitivity (95% CI) for rifampicin was 90.3% (89.6-90.9%), while for isoniazid it was 78.2% (77.4-79.0%) and their specificities were 96.3% (95.7-96.8%) and 94.4% (93.1-95.5%), respectively. For second-line drugs, sensitivity varied from 67.4% (64.1-70.6%) for capreomycin to 88.2% (85.1-90.9%) for moxifloxacin, with specificity ranging from 90.0% (87.1-92.5%) for moxifloxacin to 99.5% (99.0-99.8%) for amikacin.This study provides a standardised and comprehensive approach for the interpretation of mutations as predictors of M. tuberculosis drug-resistant phenotypes. These data have implications for the clinical interpretation of molecular diagnostics and next-generation sequencing as well as efficient individualised therapy for patients with drug-resistant tuberculosis.
- Published
- 2017
12. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
- Author
-
Biotechnology and Biological Sciences Research Council (UK), National Health and Medical Research Council (Australia), Newton Fund, Medical Research Council (UK), Fundação de Amparo à Pesquisa do Estado de São Paulo Minas Gerais, Coll, Francesc [0000-0002-7882-2325], Phelan, Jody, Coll, Francesc, McNerney, Ruth, Ascher, David B., Pires, Douglas E. V., Furnham, Nick, Coeck, Nele, Hill-Cawthorne, Grant A., Nair, Mridul B., Mallard, Kim, Ramsay, Andrew, Campino, Susana, Hibberd, Martin L., Pain, Arnab, Rigouts, Leen, Clark, Taane G., Biotechnology and Biological Sciences Research Council (UK), National Health and Medical Research Council (Australia), Newton Fund, Medical Research Council (UK), Fundação de Amparo à Pesquisa do Estado de São Paulo Minas Gerais, Coll, Francesc [0000-0002-7882-2325], Phelan, Jody, Coll, Francesc, McNerney, Ruth, Ascher, David B., Pires, Douglas E. V., Furnham, Nick, Coeck, Nele, Hill-Cawthorne, Grant A., Nair, Mridul B., Mallard, Kim, Ramsay, Andrew, Campino, Susana, Hibberd, Martin L., Pain, Arnab, Rigouts, Leen, and Clark, Taane G.
- Abstract
Background: Combating the spread of drug resistant tuberculosis is a global health priority. Whole genome association studies are being applied to identify genetic determinants of resistance to anti-tuberculosis drugs. Protein structure and interaction modelling are used to understand the functional effects of putative mutations and provide insight into the molecular mechanisms leading to resistance. Methods: To investigate the potential utility of these approaches, we analysed the genomes of 144 Mycobacterium tuberculosis clinical isolates from The Special Programme for Research and Training in Tropical Diseases (TDR) collection sourced from 20 countries in four continents. A genome-wide approach was applied to 127 isolates to identify polymorphisms associated with minimum inhibitory concentrations for first-line anti-tuberculosis drugs. In addition, the effect of identified candidate mutations on protein stability and interactions was assessed quantitatively with well-established computational methods. Results: The analysis revealed that mutations in the genes rpoB (rifampicin), katG (isoniazid), inhA-promoter (isoniazid), rpsL (streptomycin) and embB (ethambutol) were responsible for the majority of resistance observed. A subset of the mutations identified in rpoB and katG were predicted to affect protein stability. Further, a strong direct correlation was observed between the minimum inhibitory concentration values and the distance of the mutated residues in the three-dimensional structures of rpoB and katG to their respective drugs binding sites. Conclusions: Using the TDR resource, we demonstrate the usefulness of whole genome association and convergent evolution approaches to detect known and potentially novel mutations associated with drug resistance. Further, protein structural modelling could provide a means of predicting the impact of polymorphisms on drug efficacy in the absence of phenotypic data. These approaches could ultimately lead to novel resistan
- Published
- 2016
13. AdvISER-PYRO: Amplicon Identification using SparsE Representation of PYROsequencing signal.
- Author
-
UCL - (SLuc) Département de médecine interne et services associés, UCL - SSS/IREC/CTMA - Centre de technologies moléculaires appliquées (plate-forme technologique), UCL - SSS/IREC/EPID - Pôle d'épidémiologie et biostatistique, Ambroise, Jérôme, Piette, Anne-Sophie, Delcorps, Cathy, Rigouts, Leen, de Jong, Bouke C, Irenge, Leonid, Robert, Annie, Gala, Jean-Luc, UCL - (SLuc) Département de médecine interne et services associés, UCL - SSS/IREC/CTMA - Centre de technologies moléculaires appliquées (plate-forme technologique), UCL - SSS/IREC/EPID - Pôle d'épidémiologie et biostatistique, Ambroise, Jérôme, Piette, Anne-Sophie, Delcorps, Cathy, Rigouts, Leen, de Jong, Bouke C, Irenge, Leonid, Robert, Annie, and Gala, Jean-Luc
- Abstract
MOTIVATION: Converting a pyrosequencing signal into a nucleotide sequence appears highly challenging when signal intensities are low (unitary peak heights ) or when complex signals are produced by several target amplicons. In these cases, the pyrosequencing software fails to provide correct nucleotide sequences. Accordingly, the objective was to develop the AdvISER-PYRO algorithm, performing an automated, fast and reliable analysis of pyrosequencing signals that circumvents those limitations. RESULTS: In the current mycobacterial amplicon genotyping application, AdvISER-PYRO performed much better than the pyrosequencing software in the following two situations: when converting Single Amplicon Sample (SAS) signals into a correct single sequence (97.2% versus 56.5%), and when translating Multiple Amplicon Sample (MAS) signals into the correct sequence pair (74.5%). AVAILABILITY: AdvISER-PYRO is implemented in an R package (http://sites.uclouvain.be/md-ctma/index.php/softwares) and can be used in broad range of clinical applications including multiplex pyrosequencing and oncogene re-sequencing in heterogeneous tumor cell samples.
- Published
- 2013
14. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda
- Author
-
Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Dediste, Anne, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Dediste, Anne, Struelens, Marc, and Portaels, Françoise
- Abstract
Background: Multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic problem in many parts of the world, necessitating the inclusion of second-line anti-tuberculosis drugs in specific treatment regimens. Methods: We studied the susceptibility of 69 MDR Mycobacterium tuberculosis isolates from Rwanda to second-line drugs by the BACTEC 460 method. Results: The results showed that 62 (89.9%) were resistant to rifabutin while a low rate (4.3%) of resistance was registered for ofloxacin; there was one case (1.4%) of resistance each for para-aminosalicylic acid, kanamycin, ethionamide, and clarithromycin. Conclusions: This information is important for devising an appropriate treatment regimen for MDR-TB patients in order to stop the spread of MDR strains and contain the acquisition of additional drug resistance in Rwanda. © 2007 International Society for Infectious Diseases., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2008
15. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda
- Author
-
Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Dediste, Anne, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Dediste, Anne, Struelens, Marc, and Portaels, Françoise
- Abstract
Background: Multidrug-resistant tuberculosis (MDR-TB) has become a therapeutic problem in many parts of the world, necessitating the inclusion of second-line anti-tuberculosis drugs in specific treatment regimens. Methods: We studied the susceptibility of 69 MDR Mycobacterium tuberculosis isolates from Rwanda to second-line drugs by the BACTEC 460 method. Results: The results showed that 62 (89.9%) were resistant to rifabutin while a low rate (4.3%) of resistance was registered for ofloxacin; there was one case (1.4%) of resistance each for para-aminosalicylic acid, kanamycin, ethionamide, and clarithromycin. Conclusions: This information is important for devising an appropriate treatment regimen for MDR-TB patients in order to stop the spread of MDR strains and contain the acquisition of additional drug resistance in Rwanda. © 2007 International Society for Infectious Diseases., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2008
16. Evidence of 'amplifier effect' in pulmonary multidrug-resistant tuberculosis: report of three cases
- Author
-
Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Struelens, Marc, and Portaels, Françoise
- Abstract
Introduction: A cluster of three related cases of tuberculosis (TB) with primary multidrug resistance was investigated at the Centre Hospitalier Universitaire of Kigali (CHUK) in Rwanda. The patients were HIV-1/2 seronegative. Patients 1 and 2 were hospitalized in the same room of CHUK for one month. Patient 3 was a younger sibling of patient 2. Methods: Drug susceptibility of two consecutive Mycobacterium tuberculosis isolates from each patient was tested by the BACTEC 460 radiometric method. DNA fingerprinting was performed using spoligotyping and mycobacterial interspersed repetitive units of variable numbers of tandem repeats (MIRU-VNTR) analysis. All patients initially received the World Health Organization category I regimen. Results: The isolates collected during the first TB episode were resistant to isoniazid, rifampin and ethambutol. After subsequent retreatment regimens with rifampin, isoniazid, streptomycin, pyrazinamide (8 months) and rifampin, isoniazid, streptomycin, pyrazinamide, ciprofloxacin (21 months), patients 1 and 2 developed additional resistance to streptomycin and quinolones. Patient 3 received only the category I regimen and consecutive isolates retained the initial drug susceptibility pattern. All isolates were genetically indistinguishable by spoligotyping and MIRU-VNTR, indicating the same origin. Conclusions: These observations highlight the risk of nosocomial transmission of multidrug-resistant (MDR) TB and the possible selection of secondary resistance to second-line drugs if a single new drug is added at the time of retreatment of MDR TB patients. © 2007 International Society for Infectious Diseases., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
17. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda
- Author
-
Umubyeyi, Alaine Nyaruhirira, Vandebriel, Greet, Gasana, Michel, Basinga, Paulin, Zawadi, J.P., Gatabazi, J., Pauwels, Paul, Nzabintwali, F., Nyiramasarabwe, L., Fissette, Krista, Rigouts, Leen, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Vandebriel, Greet, Gasana, Michel, Basinga, Paulin, Zawadi, J.P., Gatabazi, J., Pauwels, Paul, Nzabintwali, F., Nyiramasarabwe, L., Fissette, Krista, Rigouts, Leen, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: re.j, info:eu-repo/semantics/published
- Published
- 2007
18. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: Results of a national survey
- Author
-
Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Fissette, Krista, Elkrim, Yvon, De Rijk, Peter, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Fissette, Krista, Elkrim, Yvon, De Rijk, Peter, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
19. Molecular investigation of recurrent tuberculosis in patients from Rwanda
- Author
-
Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Karita, Etienne, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Karita, Etienne, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
20. Résistance primaire et acquise aux antituberculeux des souches de Mycobacterium tuberculosis isolées au Rwanda
- Author
-
Umubyeyi Nyaruhirira, A.N., Rigouts, Leen, Zissis, Georges, Kamanzi, E., Pauwels, Paul, Gasana, Michel, Vandebriel, Greet, Struelens, Marc, Portaels, Françoise, Umubyeyi Nyaruhirira, A.N., Rigouts, Leen, Zissis, Georges, Kamanzi, E., Pauwels, Paul, Gasana, Michel, Vandebriel, Greet, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
21. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda
- Author
-
Umubyeyi, Alaine Nyaruhirira, Vandebriel, Greet, Gasana, Michel, Basinga, Paulin, Zawadi, J.P., Gatabazi, J., Pauwels, Paul, Nzabintwali, F., Nyiramasarabwe, L., Fissette, Krista, Rigouts, Leen, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Vandebriel, Greet, Gasana, Michel, Basinga, Paulin, Zawadi, J.P., Gatabazi, J., Pauwels, Paul, Nzabintwali, F., Nyiramasarabwe, L., Fissette, Krista, Rigouts, Leen, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: re.j, info:eu-repo/semantics/published
- Published
- 2007
22. Molecular investigation of recurrent tuberculosis in patients from Rwanda
- Author
-
Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Karita, Etienne, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Karita, Etienne, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
23. Evidence of 'amplifier effect' in pulmonary multidrug-resistant tuberculosis: report of three cases
- Author
-
Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Shamputa, Isdore Chola, Rigouts, Leen, Dediste, Anne, Struelens, Marc, and Portaels, Françoise
- Abstract
Introduction: A cluster of three related cases of tuberculosis (TB) with primary multidrug resistance was investigated at the Centre Hospitalier Universitaire of Kigali (CHUK) in Rwanda. The patients were HIV-1/2 seronegative. Patients 1 and 2 were hospitalized in the same room of CHUK for one month. Patient 3 was a younger sibling of patient 2. Methods: Drug susceptibility of two consecutive Mycobacterium tuberculosis isolates from each patient was tested by the BACTEC 460 radiometric method. DNA fingerprinting was performed using spoligotyping and mycobacterial interspersed repetitive units of variable numbers of tandem repeats (MIRU-VNTR) analysis. All patients initially received the World Health Organization category I regimen. Results: The isolates collected during the first TB episode were resistant to isoniazid, rifampin and ethambutol. After subsequent retreatment regimens with rifampin, isoniazid, streptomycin, pyrazinamide (8 months) and rifampin, isoniazid, streptomycin, pyrazinamide, ciprofloxacin (21 months), patients 1 and 2 developed additional resistance to streptomycin and quinolones. Patient 3 received only the category I regimen and consecutive isolates retained the initial drug susceptibility pattern. All isolates were genetically indistinguishable by spoligotyping and MIRU-VNTR, indicating the same origin. Conclusions: These observations highlight the risk of nosocomial transmission of multidrug-resistant (MDR) TB and the possible selection of secondary resistance to second-line drugs if a single new drug is added at the time of retreatment of MDR TB patients. © 2007 International Society for Infectious Diseases., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
24. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: Results of a national survey
- Author
-
Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Fissette, Krista, Elkrim, Yvon, De Rijk, Peter, Struelens, Marc, Portaels, Françoise, Umubyeyi, Alaine Nyaruhirira, Rigouts, Leen, Shamputa, Isdore Chola, Fissette, Krista, Elkrim, Yvon, De Rijk, Peter, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
25. Résistance primaire et acquise aux antituberculeux des souches de Mycobacterium tuberculosis isolées au Rwanda
- Author
-
Umubyeyi Nyaruhirira, A.N., Rigouts, Leen, Zissis, Georges, Kamanzi, E., Pauwels, Paul, Gasana, Michel, Vandebriel, Greet, Struelens, Marc, Portaels, Françoise, Umubyeyi Nyaruhirira, A.N., Rigouts, Leen, Zissis, Georges, Kamanzi, E., Pauwels, Paul, Gasana, Michel, Vandebriel, Greet, Struelens, Marc, and Portaels, Françoise
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2007
26. Mycobacterium tuberculosis complex genetic diversity:Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
- Author
-
Brudey, Karine, Driscoll, Jeffrey R., Rigouts, Leen, Prodinger, Wolfgang M., Gori, Andrea, Al-Hajoj, Sahal A., Allix, Caroline, Aristimuño, Liselotte, Arora, Jyoti, Baumanis, Viesturs, Binder, Lothar, Cafrune, Patricia, Cataldi, Angel, Cheong, Soonfatt, Diel, Roland, Ellermeier, Christopher, Evans, Jason T., Fauville-Dufaux, Maryse, Ferdinand, Séverine, De Viedma, Dario Garcia, Garzelli, Carlo, Gazzola, Lidia, Gomes, Harrison M., Guttierez, M. Cristina, Hawkey, Peter M., Van Helden, Paul D., Kadival, Gurujaj V., Kreiswirth, Barry N., Kremer, Kristin, Kubin, Milan, Kulkarni, Savita P., Liens, Benjamin, Lillebaek, Troels, Ho, Minh Ly, Martin, Carlos, Martin, Christian, Mokrousov, Igor, Narvskaïa, Olga, Yun, Fong Ngeow, Naumann, Ludmilla, Niemann, Stefan, Parwati, Ida, Rahim, Zeaur, Rasolofo-Razanamparany, Voahangy, Rasolonavalona, Tiana, Rossetti, M. Lucia, Rüsch-Gerdes, Sabine, Sajduda, Anna, Samper, Sofia, Shemyakin, Igor G., Brudey, Karine, Driscoll, Jeffrey R., Rigouts, Leen, Prodinger, Wolfgang M., Gori, Andrea, Al-Hajoj, Sahal A., Allix, Caroline, Aristimuño, Liselotte, Arora, Jyoti, Baumanis, Viesturs, Binder, Lothar, Cafrune, Patricia, Cataldi, Angel, Cheong, Soonfatt, Diel, Roland, Ellermeier, Christopher, Evans, Jason T., Fauville-Dufaux, Maryse, Ferdinand, Séverine, De Viedma, Dario Garcia, Garzelli, Carlo, Gazzola, Lidia, Gomes, Harrison M., Guttierez, M. Cristina, Hawkey, Peter M., Van Helden, Paul D., Kadival, Gurujaj V., Kreiswirth, Barry N., Kremer, Kristin, Kubin, Milan, Kulkarni, Savita P., Liens, Benjamin, Lillebaek, Troels, Ho, Minh Ly, Martin, Carlos, Martin, Christian, Mokrousov, Igor, Narvskaïa, Olga, Yun, Fong Ngeow, Naumann, Ludmilla, Niemann, Stefan, Parwati, Ida, Rahim, Zeaur, Rasolofo-Razanamparany, Voahangy, Rasolonavalona, Tiana, Rossetti, M. Lucia, Rüsch-Gerdes, Sabine, Sajduda, Anna, Samper, Sofia, and Shemyakin, Igor G.
- Abstract
Background: The Direct Repeat locus of the Mycobacterium tuberculosis complex (MTC) is a member of the CRISPR (Clustered regularly interspaced short palindromic repeats) sequences family. Spoligotyping is the widely used PCR-based reverse-hybridization blotting technique that assays the genetic diversity of this locus and is useful both for clinical laboratory, molecular epidemiology, evolutionary and population genetics. It is easy, robust, cheap, and produces highly diverse portable numerical results, as the result of the combination of (1) Unique Events Polymorphism (UEP) (2) Insertion-Sequence- mediated genetic recombination. Genetic convergence, although rare, was also previously demonstrated. Three previous international spoligotype databases had partly revealed the global and local geographical structures of MTC bacilli populations, however, there was a need for the release of a new, more representative and extended, international spoligotyping database. Results: The fourth international spoligotyping database, SpolDB4, describes 1939 shared-types (STs) representative of a total of 39,295 strains from 122 countries, which are tentatively classified into 62 clades/lineages using a mixed expert-based and bioinformatical approach. The SpolDB4 update adds 26 new potentially phylogeographically-specific MTC genotype families. It provides a clearer picture of the current MTC genomes diversity as well as on the relationships between the genetic attributes investigated (spoligotypes) and the infra-species classification and evolutionary history of the species. Indeed, an independent Naïve-Bayes mixture-model analysis has validated main of the previous supervised SpolDB3 classification results, confirming the usefulness of both supervised and unsupervised models as an approach to understand MTC population structure. Updated results on the epidemiological status of spoligotypes, as well as genetic prevalence maps on six main lineages are also shown. Our results sugg
- Published
- 2006
27. Mycobacterium tuberculosis complex genetic diversity:Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
- Author
-
Brudey, Karine, Driscoll, Jeffrey R., Rigouts, Leen, Prodinger, Wolfgang M., Gori, Andrea, Al-Hajoj, Sahal A., Allix, Caroline, Aristimuño, Liselotte, Arora, Jyoti, Baumanis, Viesturs, Binder, Lothar, Cafrune, Patricia, Cataldi, Angel, Cheong, Soonfatt, Diel, Roland, Ellermeier, Christopher, Evans, Jason T., Fauville-Dufaux, Maryse, Ferdinand, Séverine, De Viedma, Dario Garcia, Garzelli, Carlo, Gazzola, Lidia, Gomes, Harrison M., Guttierez, M. Cristina, Hawkey, Peter M., Van Helden, Paul D., Kadival, Gurujaj V., Kreiswirth, Barry N., Kremer, Kristin, Kubin, Milan, Kulkarni, Savita P., Liens, Benjamin, Lillebaek, Troels, Ho, Minh Ly, Martin, Carlos, Martin, Christian, Mokrousov, Igor, Narvskaïa, Olga, Yun, Fong Ngeow, Naumann, Ludmilla, Niemann, Stefan, Parwati, Ida, Rahim, Zeaur, Rasolofo-Razanamparany, Voahangy, Rasolonavalona, Tiana, Rossetti, M. Lucia, Rüsch-Gerdes, Sabine, Sajduda, Anna, Samper, Sofia, Shemyakin, Igor G., Brudey, Karine, Driscoll, Jeffrey R., Rigouts, Leen, Prodinger, Wolfgang M., Gori, Andrea, Al-Hajoj, Sahal A., Allix, Caroline, Aristimuño, Liselotte, Arora, Jyoti, Baumanis, Viesturs, Binder, Lothar, Cafrune, Patricia, Cataldi, Angel, Cheong, Soonfatt, Diel, Roland, Ellermeier, Christopher, Evans, Jason T., Fauville-Dufaux, Maryse, Ferdinand, Séverine, De Viedma, Dario Garcia, Garzelli, Carlo, Gazzola, Lidia, Gomes, Harrison M., Guttierez, M. Cristina, Hawkey, Peter M., Van Helden, Paul D., Kadival, Gurujaj V., Kreiswirth, Barry N., Kremer, Kristin, Kubin, Milan, Kulkarni, Savita P., Liens, Benjamin, Lillebaek, Troels, Ho, Minh Ly, Martin, Carlos, Martin, Christian, Mokrousov, Igor, Narvskaïa, Olga, Yun, Fong Ngeow, Naumann, Ludmilla, Niemann, Stefan, Parwati, Ida, Rahim, Zeaur, Rasolofo-Razanamparany, Voahangy, Rasolonavalona, Tiana, Rossetti, M. Lucia, Rüsch-Gerdes, Sabine, Sajduda, Anna, Samper, Sofia, and Shemyakin, Igor G.
- Abstract
Background: The Direct Repeat locus of the Mycobacterium tuberculosis complex (MTC) is a member of the CRISPR (Clustered regularly interspaced short palindromic repeats) sequences family. Spoligotyping is the widely used PCR-based reverse-hybridization blotting technique that assays the genetic diversity of this locus and is useful both for clinical laboratory, molecular epidemiology, evolutionary and population genetics. It is easy, robust, cheap, and produces highly diverse portable numerical results, as the result of the combination of (1) Unique Events Polymorphism (UEP) (2) Insertion-Sequence- mediated genetic recombination. Genetic convergence, although rare, was also previously demonstrated. Three previous international spoligotype databases had partly revealed the global and local geographical structures of MTC bacilli populations, however, there was a need for the release of a new, more representative and extended, international spoligotyping database. Results: The fourth international spoligotyping database, SpolDB4, describes 1939 shared-types (STs) representative of a total of 39,295 strains from 122 countries, which are tentatively classified into 62 clades/lineages using a mixed expert-based and bioinformatical approach. The SpolDB4 update adds 26 new potentially phylogeographically-specific MTC genotype families. It provides a clearer picture of the current MTC genomes diversity as well as on the relationships between the genetic attributes investigated (spoligotypes) and the infra-species classification and evolutionary history of the species. Indeed, an independent Naïve-Bayes mixture-model analysis has validated main of the previous supervised SpolDB3 classification results, confirming the usefulness of both supervised and unsupervised models as an approach to understand MTC population structure. Updated results on the epidemiological status of spoligotypes, as well as genetic prevalence maps on six main lineages are also shown. Our results sugg
- Published
- 2006
28. Mycobacterium tuberculosis complex genetic diversity:Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
- Author
-
Brudey, Karine, Driscoll, Jeffrey R., Rigouts, Leen, Prodinger, Wolfgang M., Gori, Andrea, Al-Hajoj, Sahal A., Allix, Caroline, Aristimuño, Liselotte, Arora, Jyoti, Baumanis, Viesturs, Binder, Lothar, Cafrune, Patricia, Cataldi, Angel, Cheong, Soonfatt, Diel, Roland, Ellermeier, Christopher, Evans, Jason T., Fauville-Dufaux, Maryse, Ferdinand, Séverine, De Viedma, Dario Garcia, Garzelli, Carlo, Gazzola, Lidia, Gomes, Harrison M., Guttierez, M. Cristina, Hawkey, Peter M., Van Helden, Paul D., Kadival, Gurujaj V., Kreiswirth, Barry N., Kremer, Kristin, Kubin, Milan, Kulkarni, Savita P., Liens, Benjamin, Lillebaek, Troels, Ho, Minh Ly, Martin, Carlos, Martin, Christian, Mokrousov, Igor, Narvskaïa, Olga, Yun, Fong Ngeow, Naumann, Ludmilla, Niemann, Stefan, Parwati, Ida, Rahim, Zeaur, Rasolofo-Razanamparany, Voahangy, Rasolonavalona, Tiana, Rossetti, M. Lucia, Rüsch-Gerdes, Sabine, Sajduda, Anna, Samper, Sofia, Shemyakin, Igor G., Brudey, Karine, Driscoll, Jeffrey R., Rigouts, Leen, Prodinger, Wolfgang M., Gori, Andrea, Al-Hajoj, Sahal A., Allix, Caroline, Aristimuño, Liselotte, Arora, Jyoti, Baumanis, Viesturs, Binder, Lothar, Cafrune, Patricia, Cataldi, Angel, Cheong, Soonfatt, Diel, Roland, Ellermeier, Christopher, Evans, Jason T., Fauville-Dufaux, Maryse, Ferdinand, Séverine, De Viedma, Dario Garcia, Garzelli, Carlo, Gazzola, Lidia, Gomes, Harrison M., Guttierez, M. Cristina, Hawkey, Peter M., Van Helden, Paul D., Kadival, Gurujaj V., Kreiswirth, Barry N., Kremer, Kristin, Kubin, Milan, Kulkarni, Savita P., Liens, Benjamin, Lillebaek, Troels, Ho, Minh Ly, Martin, Carlos, Martin, Christian, Mokrousov, Igor, Narvskaïa, Olga, Yun, Fong Ngeow, Naumann, Ludmilla, Niemann, Stefan, Parwati, Ida, Rahim, Zeaur, Rasolofo-Razanamparany, Voahangy, Rasolonavalona, Tiana, Rossetti, M. Lucia, Rüsch-Gerdes, Sabine, Sajduda, Anna, Samper, Sofia, and Shemyakin, Igor G.
- Abstract
Background: The Direct Repeat locus of the Mycobacterium tuberculosis complex (MTC) is a member of the CRISPR (Clustered regularly interspaced short palindromic repeats) sequences family. Spoligotyping is the widely used PCR-based reverse-hybridization blotting technique that assays the genetic diversity of this locus and is useful both for clinical laboratory, molecular epidemiology, evolutionary and population genetics. It is easy, robust, cheap, and produces highly diverse portable numerical results, as the result of the combination of (1) Unique Events Polymorphism (UEP) (2) Insertion-Sequence- mediated genetic recombination. Genetic convergence, although rare, was also previously demonstrated. Three previous international spoligotype databases had partly revealed the global and local geographical structures of MTC bacilli populations, however, there was a need for the release of a new, more representative and extended, international spoligotyping database. Results: The fourth international spoligotyping database, SpolDB4, describes 1939 shared-types (STs) representative of a total of 39,295 strains from 122 countries, which are tentatively classified into 62 clades/lineages using a mixed expert-based and bioinformatical approach. The SpolDB4 update adds 26 new potentially phylogeographically-specific MTC genotype families. It provides a clearer picture of the current MTC genomes diversity as well as on the relationships between the genetic attributes investigated (spoligotypes) and the infra-species classification and evolutionary history of the species. Indeed, an independent Naïve-Bayes mixture-model analysis has validated main of the previous supervised SpolDB3 classification results, confirming the usefulness of both supervised and unsupervised models as an approach to understand MTC population structure. Updated results on the epidemiological status of spoligotypes, as well as genetic prevalence maps on six main lineages are also shown. Our results sugg
- Published
- 2006
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.